共 50 条
- [45] Pembrolizumab for relapsed or refractory Hodgkin lymphoma LANCET ONCOLOGY, 2020, 22 (06): : E234 - E234
- [46] Synchronous Hodgkin’s lymphoma and schwannomas mimicking refractory Hodgkin’s lymphoma Annals of Hematology, 2015, 94 : 1593 - 1595